GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » Gross Margin %

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Gross Margin % : 28.67% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Qianjiang Yongan Pharmaceutical Co's Gross Profit for the three months ended in Mar. 2024 was ¥56.4 Mil. Qianjiang Yongan Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥196.6 Mil. Therefore, Qianjiang Yongan Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2024 was 28.67%.

Warning Sign:

Qianjiang Yongan Pharmaceutical Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.1%.


The historical rank and industry rank for Qianjiang Yongan Pharmaceutical Co's Gross Margin % or its related term are showing as below:

SZSE:002365' s Gross Margin % Range Over the Past 10 Years
Min: 15.44   Med: 25.77   Max: 36.48
Current: 25.34


During the past 13 years, the highest Gross Margin % of Qianjiang Yongan Pharmaceutical Co was 36.48%. The lowest was 15.44%. And the median was 25.77%.

SZSE:002365's Gross Margin % is ranked worse than
83.15% of 985 companies
in the Drug Manufacturers industry
Industry Median: 47 vs SZSE:002365: 25.34

Qianjiang Yongan Pharmaceutical Co had a gross margin of 28.67% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Qianjiang Yongan Pharmaceutical Co was -2.10% per year.


Qianjiang Yongan Pharmaceutical Co Gross Margin % Historical Data

The historical data trend for Qianjiang Yongan Pharmaceutical Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianjiang Yongan Pharmaceutical Co Gross Margin % Chart

Qianjiang Yongan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.26 30.38 22.90 32.94 25.87

Qianjiang Yongan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.10 35.99 26.16 3.66 28.67

Competitive Comparison of Qianjiang Yongan Pharmaceutical Co's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Qianjiang Yongan Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianjiang Yongan Pharmaceutical Co's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianjiang Yongan Pharmaceutical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Qianjiang Yongan Pharmaceutical Co's Gross Margin % falls into.



Qianjiang Yongan Pharmaceutical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Qianjiang Yongan Pharmaceutical Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=251.7 / 972.89
=(Revenue - Cost of Goods Sold) / Revenue
=(972.89 - 721.213) / 972.89
=25.87 %

Qianjiang Yongan Pharmaceutical Co's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=56.4 / 196.645
=(Revenue - Cost of Goods Sold) / Revenue
=(196.645 - 140.271) / 196.645
=28.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Qianjiang Yongan Pharmaceutical Co  (SZSE:002365) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Qianjiang Yongan Pharmaceutical Co had a gross margin of 28.67% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Qianjiang Yongan Pharmaceutical Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100
Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.
Executives
Mei Song Lin Executives
Wang Zhi Hua Executives
Hong Ren Gui Executives
Wu Yu Xi Directors, executives
Dai Xiang Zhen Executives
Wu Xiao Bo Directors, executives
Luo Bai Neng Executives
Ding Hong Li Directors, executives
Fang Xi Quan Executives
Li Shao Bo Executives
Deng Yong Hong Securities Affairs Representative
Dong Shi Hao Executives
Wu Guo Sen Supervisors
Lv Xin Wu Executives
Chen Yong Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines